[{"address1": "680 George Street", "address2": "Level 12", "city": "Sydney", "state": "NSW", "zip": "2000", "country": "Australia", "phone": "61 2 8280 7355", "website": "https://www.elixinolwellness.com", "industry": "Drug Manufacturers - Specialty & Generic", "industryKey": "drug-manufacturers-specialty-generic", "industryDisp": "Drug Manufacturers - Specialty & Generic", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Elixinol Wellness Limited, through its subsidiaries, engages in the manufacture and distribution of hemp derived nutraceuticals, skincare, and food products in the Americas, Europe, and Australia. It offers hemp derived cannabidiol and food products, dietary supplements, topicals, and skincare products. The company was formerly known as Elixinol Global Limited and changed its name to Elixinol Wellness Limited in May 2021. The company was incorporated in 2017 and is headquartered in Sydney, Australia.", "companyOfficers": [{"maxAge": 1, "name": "Ms. Josephine  Lorenz", "title": "Global CFO & Joint Company Secretary", "fiscalYear": 2023, "totalPay": 212607, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Glen  Zurcher", "title": "Account Director of Investor Relations Department", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 0.004, "open": 0.0029, "dayLow": 0.0029, "dayHigh": 0.0043, "regularMarketPreviousClose": 0.004, "regularMarketOpen": 0.0029, "regularMarketDayLow": 0.0029, "regularMarketDayHigh": 0.0043, "beta": 2.069, "volume": 230705, "regularMarketVolume": 230705, "averageVolume": 102845, "averageVolume10days": 179063, "averageDailyVolume10Day": 179063, "marketCap": 4553745, "fiftyTwoWeekLow": 0.0025, "fiftyTwoWeekHigh": 0.0211, "priceToSalesTrailing12Months": 0.5507008, "fiftyDayAverage": 0.0060718, "twoHundredDayAverage": 0.006567, "currency": "USD", "enterpriseValue": 2768584, "profitMargins": -0.90785, "floatShares": 536758399, "sharesOutstanding": 1301069952, "heldPercentInsiders": 0.09423, "heldPercentInstitutions": 0.0687, "impliedSharesOutstanding": 1862499968, "bookValue": 0.01, "priceToBook": 0.35000002, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1703980800, "netIncomeToCommon": -7507000, "trailingEps": -0.01, "enterpriseToRevenue": 0.335, "enterpriseToEbitda": -0.468, "52WeekChange": -0.822335, "SandP52WeekChange": 0.21231294, "exchange": "PNK", "quoteType": "EQUITY", "symbol": "ELLXF", "underlyingSymbol": "ELLXF", "shortName": "ELIXINOL WELLNESS LTD", "longName": "Elixinol Wellness Limited", "firstTradeDateEpochUtc": 1528205400, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "6c7d575b-d8fe-33de-b8ef-217a97099876", "messageBoardId": "finmb_545070079", "gmtOffSetMilliseconds": -14400000, "currentPrice": 0.0035, "recommendationKey": "none", "totalCash": 708000, "totalCashPerShare": 0.001, "ebitda": -5921000, "totalDebt": 1262000, "quickRatio": 0.487, "currentRatio": 1.639, "totalRevenue": 8269000, "debtToEquity": 19.53, "revenuePerShare": 0.017, "returnOnAssets": -0.29985002, "returnOnEquity": -0.9612, "freeCashflow": -2109625, "operatingCashflow": -2758000, "revenueGrowth": 0.254, "grossMargins": 0.39497003, "ebitdaMargins": -0.71605, "operatingMargins": -0.58682996, "financialCurrency": "AUD", "trailingPegRatio": null, "__fetch_time": "2024-04-19"}]